Medisico plc - Allotment of shares

12 March 2015

                                 Medisico plc

                         ("Medisico" or "the Company")

                              Allotment of Shares

The directors are pleased to make the following announcements relating to the
allotment of shares to new directors appointed at a board meeting held on 14
January 2015, approved by way of a written resolution signed by all directors.

 1. 2,000,000 new Ordinary Shares of nominal value of £0.001 each in the Share
    Capital of the Company were allotted at an issue price of £0.01 each to
    Andrew Britton, on his appointment as a statutory director and Chief
    Financial Officer of the Company in accordance with his Directors Service
    Agreement.

 2. 3,000,000 new Ordinary Shares of nominal value of £0.001 each in the Share
    Capital of the Company were allotted at an issue price of £0.01 each to
    Simon Zokaie, on his appointment as a statutory director and Chief Medical
    Officer of the Company in accordance with his Directors Service Agreement.

 3. 2,000,000 new Ordinary Shares of nominal value of £0.001 each in the Share
    Capital of the Company were allotted at an issue price of £0.01 each to
    Kevin Eley, on his appointment as a Sales Director of the Company in
    accordance with his Directors Service Agreement.

 4. 1,000,000 new Ordinary Shares of nominal value of £0.001 each in the Share
    Capital of the Company were allotted at an issue price of £0.01 each to
    Dr.Roger Dainty, on his appointment as a non-executive director of the
    Company in accordance with his letter of appointment.

Total paid up issued share capital after the above allotment of shares is £
159,250 divided into 159,250,000 Ordinary shares of £0.001 each.

The directors of Medisico accept responsibility for this announcement.

Disclaimer

This Document includes "forward-looking statements." All statements other than
statements of historical fact within this Document, including statements
regarding Medisico plc, plans, objectives and expectations, are all
forward-looking statements. Although Medisico plc believes that the
expectations reflected in such forward-looking statements are reasonable at
this time, it can give no assurance that such expectations will prove to have
been correct. There will always be factors beyond the Company's control that
may cause actual results to differ materially from expectations. As such
subsequent written and oral forward-looking statements attributable to Medisico
plc or persons acting on its behalf are expressly qualified in this regard.

Copyright h 12 PR Newswire

Meldex (LSE:MDX)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024 Plus de graphiques de la Bourse Meldex
Meldex (LSE:MDX)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024 Plus de graphiques de la Bourse Meldex